Biphasic insulin aspart 30 (BIAsp 30) in clinical reality: Experience from a Dutch practice

被引：0

|

作者：

Ligthelm, Robert J.

机构：

来源：

DIABETES | 2007年 / 56卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A540 / A540

页数：1

相关论文

共 50 条

[41] Insulin Degludec/Insulin Aspart (IDegAsp) Provides Superior FPG Control and Reduced Hypoglycaemia vs. Biphasic Insulin Aspart 30 (BIAsp 30) in Insulin-Naive Adults with Type 2 Diabetes in a Randomized Phase 3 Trial
Franek, Edward
Haluzik, Martin
Canecki-Varzic, Silvija
Sargin, Mehmet
Macura, Stanislava
Zacho, Jeppe
Christiansen, Jens Sandahl
DIABETES, 2014, 63 : A225 - A225
[42] Once daily initiation with biphasic insulin aspart 30 (BIAsp 30) versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs - a randomized controlled trial
Franek, E.
Kalra, S.
Pesic, M.
Smahelova, A.
Thomsen, H.
Strojek, K.
DIABETOLOGIA, 2009, 52 : S93 - S93
[43] Assessment of quality of life in patients with type 2 diabetes mellitus before and after starting biphasic insulin aspart 30 (BIAsp 30) therapy: IMPROVE study in Japan
Ishii, Hitoshi
Iwase, Masanori
Seino, Hiroaki
Shuto, Yujin
Atsumi, Yoshihito
CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (03) : 643 - 650
[44] The IMPROVE study, an observational study of initiation of insulin biphasic BIAsp30 in clinical practice. Circumstances of initiation, tolerance and efficacy
Valnsi, P.
DIABETES & METABOLISM, 2009, 35 : A57 - A57
[45] Premixed insulin aspart 30 (BIAsp 30) versus premixed human insulin 30 (BHI 30) in gestational diabetes mellitus: a randomized open-label controlled study
Balaji, Vijayam
Balaji, Madhuri S.
Alexander, Cynthia
Srinivasan, Ashalata
Suganthi, Sheela R.
Thiyagarajah, Arthi
Seshiah, Veerasamy
GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (07) : 529 - 532
[46] Biphasic insulin aspart 30: A guide to its use in diabetes mellitus
Hines M.
Lyseng-Williamson K.W.
Drugs & Therapy Perspectives, 2013, 29 (5) : 135 - 140
[47] Better glycaemic control for 30,171 insulin-naive patients with type 2 diabetes after starting biphasic insulin aspart 30/70 (BIAsp 30) therapy:: IMPROVE™ study subgroup analysis
Kawamori, R.
Srishyla, M. V.
Wenying, Y.
DIABETOLOGIA, 2008, 51 : S393 - S394
[48] Biphasic insulin aspart 30 for the treatment of type 1 diabetes mellitus
Velasquez-Mieyer, Pedro A.
Neira, Claudia P.
EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (13) : 2377 - 2382
[49] Reduction in Insulin Dose Following Shift from Biphasic Human Insulin to Biphasic Insulin Aspart30/70: Experience from Indian-Cohort of IMPROVE™ Study
Shah, Siddharth
Banerjee, Samar
Lamba, P. S.
Chakkarwar, Praful N.
Prusty, Vinay
Moharana, Ashok Kumar
Mazumdar, Anirban
DIABETES, 2009, 58 : A534 - A535
[50] Switching to biphasic insulin aspart 30/50/70 from biphasic human insulin 30/50 in patients with type 2 diabetes in normal clinical practice: observational study results (vol 28, pg 1017, 2012)
Nobels, F.
D'Hooge, D.
Crenier, L.
CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (09) : 1546 - 1546

← 1 2 3 4 5 →